Three IPOs to hit the market next week
newslivenation Three firms will launch preliminary public choices (IPOs) price ₹3,160 crore next week, hoping to profit from an fairness market awash with liquidity and a pointy improve in new retail…
Economy
Stocks hit six-week low as tech slide accelerates
Technology shares pushed U.S. shares to a six-week low as buyers searched for brand new catalysts to offer path to international markets. Crude oil reversed earlier features and Treasuries had…
Pharma stocks today have their best day in over a month. Cipla, Dr Reddy’s surge
Indian inventory markets gave up early positive factors to finish decrease today, led by losses in banking stocks. On the opposite hand, positive factors in pharma stocks helped cap losses.…
CAMS, Chemcon Speciality Chemicals, Angel Broking IPOs open next week: 10 points
After the sturdy investor response to Happiest Minds and Route Mobile IPO, three extra points will open next week: CAMS, Chemcon Speciality Chemicals and Angel Broking. The new points are…
Angel Broking to tap primary markets with ₹600 crore issue on 22 September
Riding on the robust wave of retail traders flocking to inventory markets, brokerage agency Angel Broking will open its ₹600 crore preliminary public providing (IPO) on 22 September. The worth…
Nilesh Shah recommends new category to Sebi amid tweaks in multi cap fund rules
Nilesh Shah, Chairman Amfi and Managing Director, Kotak Mahindra Mutual Fund, has requested Sebi to kind a new category, referred to as ‘flexi cap’ to keep away from big disturbance…
CAMS IPO opens on Monday: 10 things to know
The IPO of CAMS, which acts as a registrar and switch agent (RTA) for mutual funds, opens on Monday and closes on September 23. The value band has been set…
Chemcon Speciality Chemicals IPO fixes price band at ₹338- ₹340
Manufacturer of speciality chemical compounds Chemcon Speciality Chemicals Limited on Friday mounted price band at ₹338- ₹340 per share for its preliminary public providing (IPO). The three-day share sale will…
Cadila Healthcare gains 6% on US FDA nod for mineral supplement
MUMBAI : Shares of Cadila Healthcare climbed as a lot as 6.49% on Monday after the corporate obtained US drug regulator’s closing approval for Potassium Chloride extended-release tablets. At 01:50…
Mutual fund buying rules changed. What NAV will be applicable?
On Thursday, Sebi issued a mutual fund round to alter the NAV rules. From January 1, traders will get the acquisition NAV of the day when investor’s cash attain AMC.…
Dr Reddy’s Revlimid settlement to boost US earnings beyond FY23
Dr Reddy’s Laboratories’ settlement with Celgene on Revlimid patents is a constructive, and can open up alternatives within the US market, post-FY23. After a number of beneficial rulings within the…
Dr Reddy’s Lab shares today hit new highs, extend weekly gains to 20%
Shares of Dr Reddy’s Laboratories today jumped as a lot as 10% to extend its weekly gains to 20% after the drugmaker settled a patent litigation with Celgene, a unit…
Wall Street is set to start trading in a new commodity: Water
If the report warmth and wildfires ravaging California weren’t a clear sufficient signal that the local weather is altering, then think about this: Wall Street is about to start trading…
Motilal Oswal Mutual Fund clarify investors of ‘Multicap 35 Fund’ on Sebi’s rule
Motilal Oswal Mutual Fund wrote to the investors to debate the impression of Sebi’s portfolio allocation guidelines for multi cap funds on Motilal Oswal Multicap 35 Fund. Sebi just lately…
Gold prices today struggle, remains ₹5,000 lower than last month’s highs
Gold and silver prices ticked greater in Indian markets as the valuable metals proceed to commerce in a slender vary. On MCX, gold futures rose 0.2% to ₹51,571 per 10…